Anti-Infectives
Terbinafine resolves E. jeanselmei infection in heart transplant recipient
Published in TB and Outbreaks Week, July 20th, 2004
According to a case report from Minnesota, an "immunosuppressed heart transplant recipient developed Exophiala jeanselmei infection on the second toe."
"After unsuccessful treatment with different antifungal drugs, the infection responded to a high-dose regimen of oral terbinafine (an antifungal agent not yet approved in the United States for use against the dematiaceous fungi) and warm packs," stated W.A. Agger and coauthors working at the Mayo Clinic in Rochester.
"This is, to our knowledge, the only known case of successful terbinafine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- HIV/AIDS Transmission
HLA-DRB1 and -DQB1 variants associated with HIV-1 transmission events - Infectious Disease
Brugia Rapid test detects filaria-specific IgG4 antibodies in endemic areas - Neuroscience
Brain emboli dissemination after captive bolt stunning can spread BSE in animal - Parasitology
S. mekongi discovery has implications for schistosomiasis-control strategies - Water-Borne Illness
Role of bacteria in arsenic poisoning examined - Atherosclerosis
Chlamydia pneumoniae may be an infectious risk factor for atherosclerosis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
